Arrisgado, Baby Boy -.
HRN: 27-51-23 Sex: MalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
07/21/2025
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
07/21/2025
07/28/2025
IV
49mg
Q24H
NAMF (UTI)
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Bloodstream Compliance to guidelines: Compliant To Guidelines
Initial appropriateness: Yes
Final appropriateness: Yes
Overall appropriateness: Yes